BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22182786)

  • 1. Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone.
    Chen XJ; Xiao JP; Li XP; Jiang XS; Zhang Y; Xu YJ; Dai JR; Li YX
    Radiat Oncol; 2011 Dec; 6():175. PubMed ID: 22182786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone.
    Sawrie SM; Guthrie BL; Spencer SA; Nordal RA; Meredith RF; Markert JM; Cloud GA; Fiveash JB
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):181-6. PubMed ID: 17768015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases.
    Press RH; Prabhu RS; Nickleach DC; Liu Y; Shu HK; Kandula S; Patel KR; Curran WJ; Crocker I
    Cancer; 2015 Nov; 121(21):3836-43. PubMed ID: 26242475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy.
    Ayala-Peacock DN; Peiffer AM; Lucas JT; Isom S; Kuremsky JG; Urbanic JJ; Bourland JD; Laxton AW; Tatter SB; Shaw EG; Chan MD
    Neuro Oncol; 2014 Sep; 16(9):1283-8. PubMed ID: 24558022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases.
    Likhacheva A; Pinnix CC; Parikh NR; Allen PK; McAleer MF; Chiu MS; Sulman EP; Mahajan A; Guha-Thakurta N; Prabhu SS; Cahill DP; Luo D; Shiu AS; Brown PD; Chang EL
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):656-61. PubMed ID: 22898384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With 5 to 15 Brain Metastases.
    Hughes RT; McTyre ER; LeCompte M; Cramer CK; Munley MT; Laxton AW; Tatter SB; Ruiz J; Pasche B; Watabe K; Chan MD
    Neurosurgery; 2019 Aug; 85(2):257-263. PubMed ID: 29982831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis.
    McTyre E; Ayala-Peacock D; Contessa J; Corso C; Chiang V; Chung C; Fiveash J; Ahluwalia M; Kotecha R; Chao S; Attia A; Henson A; Hepel J; Braunstein S; Chan M
    Ann Oncol; 2018 Feb; 29(2):497-503. PubMed ID: 29161348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience.
    Hughes RT; Masters AH; McTyre ER; Farris MK; Chung C; Page BR; Kleinberg LR; Hepel J; Contessa JN; Chiang V; Ruiz J; Watabe K; Su J; Fiveash JB; Braunstein S; Chao S; Attia A; Ayala-Peacock DN; Chan MD
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1091-1098. PubMed ID: 30959122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
    Farris M; McTyre ER; Cramer CK; Hughes R; Randolph DM; Ayala-Peacock DN; Bourland JD; Ruiz J; Watabe K; Laxton AW; Tatter SB; Zhou X; Chan MD
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):131-141. PubMed ID: 28586952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
    Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
    Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal radiation therapy for limited brain metastases is associated with high rates of local control and low subsequent whole brain radiation therapy.
    Or M; Jayamanne D; Guo L; Stevens M; Parkinson J; Cook R; Little N; Back M
    ANZ J Surg; 2019 Apr; 89(4):418-422. PubMed ID: 30836451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Large Brain Metastases With Stereotactic Radiosurgery.
    Zimmerman AL; Murphy ES; Suh JH; Vogelbaum MA; Barnett GH; Angelov L; Ahluwalia M; Reddy CA; Chao ST
    Technol Cancer Res Treat; 2016 Feb; 15(1):186-95. PubMed ID: 25633136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.